key: cord-0716199-2mvttaaf
authors: Kimura, Kyle S.; Smetak, Miriam R.; Freeman, Michael H.; Wootten, Christopher T.
title: Undetectable viral load within the mastoid during cochlear implantation in a patient with COVID-19
date: 2021-03-02
journal: Otolaryngology case reports
DOI: 10.1016/j.xocr.2021.100273
sha: 25618a2b72bd00155f3ae086b9f3dbf7b0c41583
doc_id: 716199
cord_uid: 2mvttaaf

nan

This study was considered exempt upon review by Vanderbilt IRB. 32 Since December of 2019, the ongoing global pandemic caused by the novel coronavirus (SARS-34

CoV-2) and associated coronavirus disease-2019 (COVID-19) has had wide-reaching effects on 35 the American healthcare system and our ability to deliver routine surgical care. There is ample 36 evidence that the virus is present in high quantities within the nasopharynx and oropharynx and 37 that exposure to high viral loads, especially in the form of aerosol-generating procedures, can 38 risk viral transmission to healthcare workers. 1 As the middle ear is in continuity with the 39 nasopharynx, it is presumed that the middle ear may contain viral particles which can be 40 aerosolized during otologic procedures. This is particularly true with regards to procedures that 41 require the use of a drill, which has been shown to cause significant aerosolization of bone, Despite these concerns, there is very little evidence demonstrating the presence and natural 49 progression of SARS-CoV-2 within the middle ear to guide recommendations. We present a case 50 of a 12-month-old female who persistently tested positive for COVID-19 who ultimately 51 underwent bilateral cochlear implantation. Bilateral mastoid cavities were sampled 52 intraoperatively and found to be negative for the presence of SARS-CoV-2 despite positive viral 53 load sampled within the nasopharynx. 54

A 12-month-old female with progressive bilateral profound sensorineural hearing loss was 57 scheduled for bilateral cochlear implantation, but tested positive for COVID-19 on routine pre-58 operative asymptomatic screening. Her surgery was delayed for 6 weeks according to 59 institutional policy at that time. She remained asymptomatic during this period. However, a 60 repeat nasopharyngeal swab was again positive at 6 weeks. After thorough discussion between 61 the operative team and patient family, the decision was made to proceed with surgery with 62 appropriate precautions for aerosol-generating procedures in a COVID-19-positive patient. was not detected in either mastoid. Quantitative data is provided in Figure 1 and Table 1 . 

Guidance for otolaryngology health care workers 125 performing aerosol generating medical procedures during the COVID-19 pandemic

Otolaryngol Head Neck Surg

Demonstration and Mitigation of Aerosol and 128

Particle Dispersion During Mastoidectomy Relevant to the COVID-19 Era

Foundation Guide to Enhance Otologic and Neurotologic Care During the COVID-19 Pandemic

Middle Ear Viral Load Considerations in the 135 COVID-19 Era: A Systematic Review

COVID-19 sampling from the middle ear and 138 mastoid: A case report

Acknowledgments to Suman Das, PhD and Britton Strickland, BS for performing viral load